Augmented LPS responsiveness in type 1 diabetes‐derived osteoclasts

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cellular Physiology

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcp.24138PMID 22718269PMCID PMC3470828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1)

  2010cited by this paper
• TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1

  2010cited by this paper
• Obesity, diabetes mellitus and last but not least, osteoporosis.

  2010cited by this paper
• Cross talk between the bone and immune systems : osteoclasts function as antigen-presenting cells and activate CD 4 and CD 8 T cells

  2010cited by this paper
• Altered Fibroblast Proliferation and Apoptosis in Diabetic Gingival Wounds

  2010cited by this paper
• Recent advances in understanding the mechanisms of osteoclast precursor fusion

  2010cited by this paper
• Cellular and Molecular Mechanisms of Bone Remodeling*

  2010cited by this paper
• Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells.

  2009cited by this paper
• Osteoimmunology and the effects of the immune system on bone

  2009cited by this paper
• Diabetes and fractures: an overshadowed association

  2009cited by this paper
• High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing.

  2009cited by this paper
• Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment.

  2009cited by this paper
• Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?

  2009cited by this paper
• TNFR signaling: ubiquitin‐conjugated TRAFfic signals control stop‐and‐go for MAPK signaling complexes

  2009cited by this paper
• Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis*

  2009cited by this paper
• Canonical and non-canonical pathways of osteoclast formation.

  2009cited by this paper
• Osteoclast receptors and signaling.

  2008cited by this paper
• High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

  2008cited by this paper
• Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand

  2008cited by this paper
• Osteoclast lineage and function.

  2008cited by this paper
• The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.

  2008cited by this paper
• Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy

  2008cited by this paper
• Diabetes mellitus and inflammatory periodontal diseases

  2008cited by this paper
• Evaluation of Cytokine Production from Peripheral Blood Mononuclear Cells of Type 1 Diabetic Patients

  2008cited by this paper
• Osteoclast-osteoblast communication.

  2008cited by this paper
• Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice.

  2007cited by this paper
• Impact of cytokines and T lymphocytes upon osteoclast differentiation and function

  2007cited by this paper
• Diabetes mellitus promotes periodontal destruction in children

  2007cited by this paper
• Understanding the pathology and mechanisms of type I diabetic bone loss

  2007cited by this paper
• Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

  2007influential reference
• Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity

  2007cited by this paper
• The osteoclast: A multinucleated, hematopoietic‐origin, bone‐resorbing osteoimmune cell

  2007cited by this paper
• Diabetes mellitus promotes periodontal destruction in children.

  2007cited by this paper
• Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils

  2007cited by this paper
• Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

  2007cited by this paper
• Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease

  2006cited by this paper
• Protective and Destructive Immunity in the Periodontium: Part 1—Innate and Humoral Immunity and the Periodontium

  2006cited by this paper
• Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation

  2006cited by this paper
• Inflammation is More Persistent in Type 1 Diabetic Mice

  2005cited by this paper
• The NOD mouse: a model of immune dysregulation.

  2005cited by this paper
• Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

  2005cited by this paper
• Glucose is a key metabolic regulator of osteoclasts; glucose stimulated increases in ATP/ADP ratio and calmodulin kinase II activity.

  2005cited by this paper
• TNF-alpha and pathologic bone resorption.

  2005cited by this paper
• TNFα and pathologic bone resorption

  2005cited by this paper
• A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation.

  2004cited by this paper
• Diabetes alters the response to bacteria by enhancing fibroblast apoptosis.

  2004cited by this paper
• Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.

  2004cited by this paper
• Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss.

  2004cited by this paper
• Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor α, interleukin 1, and receptor activator of nuclear factor κB ligand (RANKL) regulate osteoclasts

  2004cited by this paper
• The influence of diabetes on the periodontal tissues.

  2003cited by this paper
• A role for advanced glycation end products in diminished bone healing in type 1 diabetes.

  2003cited by this paper
• Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation.

  2003cited by this paper
• The synergistic effect of peptidoglycan and lipopolysaccaride on osteoclast formation.

  2003cited by this paper
• NF-κB Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages1

  2003cited by this paper
• Glucose‐dependent regulation of osteoclast H+‐ATPase expression: Potential role of p38 MAP‐kinase

  2002cited by this paper
• Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB*

  2002cited by this paper
• Elevated NF-κB Activation in Nonobese Diabetic Mouse Dendritic Cells Results in Enhanced APC Function1

  2002cited by this paper
• Stimulation by Toll-Like Receptors Inhibits Osteoclast Differentiation1

  2002cited by this paper
• Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase.

  2001cited by this paper
• Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.

  2001cited by this paper
• Dendritic Cells from Nonobese Diabetic Mice Exhibit a Defect in NF-κB Regulation Due to a Hyperactive IκB Kinase1

  2001cited by this paper
• Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism †

  2001cited by this paper
• A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1.

  1999cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• The Th1/Th2 Paradigm and Experimental Murine Leishmaniasis

  1998cited by this paper
• Regulation of osteoclastic bone resorption by glucose.

  1997cited by this paper
• Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.

  1997cited by this paper
• Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes.

  1994cited by this paper
• Implications of Diabetes Mellitus and Periodontal Disease

  1992cited by this paper
• NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice

  1992cited by this paper
• Biomedical Image Processing

  1983cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society A Role for Interleukin-6 in Parathyroid Hormone- Induced Bone Resorption in Vivo*

  year unknowncited by this paper

• The role of O-GlcNAcylation in bone metabolic diseases

  2024cites this paper
• Diabetes mellitus exacerbates inflammation in a murine model of ligature-induced peri-implantitis: A histological and microtomographic study.

  2024cites this paper
• Mouse models of type 1 diabetes and their use in skeletal research

  2022cites this paper
• Effect of Diabetes Mellitus and Anti-Diabetic Drugs on Bone Health-A Review

  2021cites this paper
• Special Considerations to Improve Clinical Outcomes in Patients with Osteoporosis Undergoing Spine Surgery

  2021cites this paper
• Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus

  2021cites this paper
• Patients with Osteoporosis Undergoing Spine Surgery Special Considerations to Improve Clinical Outcomes in

  2021cites this paper
• State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature

  2021cites this paper
• Matrix Metalloproteinase Inspired Therapeutic Strategies for Bone Diseases.

  2020cites this paper
• Diabetes as a risk factor for periodontal disease-plausible mechanisms.

  2020cites this paper
• Эффективность комплексной консервативной пародонтальной терапии с применением щадящей методики обработки ультразвуковым аппаратом с полирующей суспензией на основе гидроокиси кальция у пациентов с сахарным диабетом 1 типа и хроническим генерализованным пародонтитом

  2019cites this paper
• Synergistic alveolar bone resorption by diabetic AGEs and mechanical forces.

  2019cites this paper
• The effectiveness of complex conservative periodontal therapy using a gentle treatment technique by ultrasonic apparatus with calcium hydroxide polishing suspension among patients with type 1 diabetes and chronic generalized periodontitis

  2019cites this paper
• An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes

  2018cites this paper
• Weak bones in diabetes mellitus – an update on pharmaceutical treatment options

  2018cites this paper
• Hyperglycemia Suppresses RANKL-Induced Osteoclast Differentiation through LXRβ Expression in RAW264.7 Cells.

  2017cites this paper
• An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes.

  2017cites this paper
• Bone Marrow Stem Cells and Bone Turnover in Diabetic Disease

  2016cites this paper
• Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts

  2016cites this paper
• Type 1 Diabetes and Osteoporosis: From Molecular Pathways to Bone Phenotype

  2015cites this paper
• The Pathobiology of Diabetes Mellitus in Bone Metabolism, Fracture Healing, and Complications.

  2015cites this paper
• Glycation of collagen interferes with discoidin domain receptor 2 (DDR2) mediated collagen induction of lysyl oxidase in osteoblasts

  2013cites this paper